-transparent.png){kind=logo}
Some N-(dipeptidyl)-S-acetylcysteamine and N,N'-(dipeptidyl)cystamine salt derivatives were synthesized and evaluated as candidate radioprotector agents. Toxicity and radioprotective activity as the dose reduction factor (DRF) were determined in vivo on mice and compared to N-glycyl-S-acetylcysteamine trifluoroacetate. One of the most interesting compounds of this series was N-glycylglycyl-S-acetylcysteamine trifluoroacetate (8).
Related Publications
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou
January 1987,
Methods in enzymology,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou
April 1957,
The American journal of physiology,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou
September 1955,
Archives internationales de physiologie et de biochimie,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou
February 1958,
Nature,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou
October 2018,
Bioscience reports,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou
October 1957,
Annales de l'Institut Pasteur,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou
April 1964,
Acta radiologica: therapy, physics, biology,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou
June 1987,
Yao xue xue bao = Acta pharmaceutica Sinica,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou
December 2004,
Experimental & molecular medicine,
J Oiry, and
J Y Pue, and
J L Imbach, and
M Fatome, and
H Sentenac-Roumanou
November 1956,
The British journal of radiology,
